Advances in PET/CT imaging for breast cancer Review


Authors: de Jong, D.; Desperito, E.; Al Feghali, K. A.; Dercle, L.; Seban, R. D.; Das, J. P.; Ma, H.; Sajan, A.; Braumuller, B.; Prendergast, C.; Liou, C.; Deng, A.; Roa, T.; Yeh, R.; Girard, A.; Salvatore, M. M.; Capaccione, K. M.
Review Title: Advances in PET/CT imaging for breast cancer
Abstract: One out of eight women will be affected by breast cancer during her lifetime. Imaging plays a key role in breast cancer detection and management, providing physicians with information about tumor location, heterogeneity, and dissemination. In this review, we describe the latest advances in PET/CT imaging of breast cancer, including novel applications of 18F-FDG PET/CT and the development and testing of new agents for primary and metastatic breast tumor imaging and therapy. Ultimately, these radiopharmaceuticals may guide personalized approaches to optimize treatment based on the patient’s specific tumor profile, and may become a new standard of care. In addition, they may enhance the assessment of treatment efficacy and lead to improved outcomes for patients with a breast cancer diagnosis. © 2023 by the authors.
Keywords: breast cancer; triple negative breast cancer (tnbc); pet radiotracers; <sup>18</sup>f-fdg
Journal Title: Journal of Clinical Medicine
Volume: 12
Issue: 13
ISSN: 2077-0383
Publisher: MDPI  
Date Published: 2023-07-01
Start Page: 4537
Language: English
DOI: 10.3390/jcm12134537
PROVIDER: scopus
PMCID: PMC10342839
PUBMED: 37445572
DOI/URL:
Notes: Review -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Randy Yeh
    68 Yeh
  2. Jeeban Paul Das
    41 Das